Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin/Ezetimibe and Telmisartan Co-administration in Hypercholesterolemia and Hypertension
NCT03872232Phase 3Completed
- Sponsor
- Addpharma, Inc.
- Start
- Feb 2019
- Primary completion
- Aug 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin, ezetimibe, telmisartan in hypercholesterolemia, essential hypertension, sponsored by Addpharma, Inc.. Started Feb 2019; status: completed.
02
Drugs
rosuvastatinezetimibetelmisartan
03
Conditions
hypercholesterolemiaessential hypertension
Beyond the preview
Go deeper on NCT03872232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03872232.